Table 2.
Participant characteristics at baseline.
| Patient Trust in Doctor | Patient Trust in Pharmacist | Total | |||
| Intact (n = 286) n (%) |
Compromised (n = 63) n (%) |
Intact (n = 284) n (%) |
Compromised (n = 64) n (%) |
(n = 352) n (%) |
|
| All participants | |||||
| Sex (female) | 186 (82.3) | 40 (17.7) | 183 (81.0) | 43 (19.0) | 226 (64.8) |
| Age in years, Mean ± SD (range) | 74.1 ± 6.4 (66–96) |
75.5 ± 6.4 (66–92) |
74.4 ± 6.6 (66–96) |
74.1 ± 5.7 (66–90) |
74.3 ± 6.4 (66–96) |
| Intent to discuss deprescribing | 179 (82.5) | 38 (17.5) | 176 (81.5) | 40 (18.5) | 216 (62.6) |
| Participants by Medication Class: | |||||
| Benzodiazepine | 166 (81.8) | 37 (18.2) | 164 (81.2) | 38 (18.8) | 203 (58.2) |
| First generation antihistamine | 11 (100) | 0 (0.0) | 11 (100) | 0 (0.0) | 11 (3.2) |
| Long acting sulfonylurea | 68 (76.4) | 21 (23.6) | 69 (77.5) | 20 (22.5) | 89 (25.5) |
| NSAID | 41 (89.1) | 5 (10.9) | 40 (87.0) | 6 (13.0) | 46 (13.2) |
SD = Standard Deviation; NSAID = Non-steroidal anti-inflammatory drug.